JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Support: [email protected]

Track Your Order

TNF-α

C4832 Maslinic Acid

Summary: inhibitor of NO, H2O2 , IL-6 and TNF-α

insoluble in H2O; insoluble in EtOH; ≥10.7 mg/mL
C3129 R-7050

Summary: TNF-α receptor signaling antagonist,cell-permeable

insoluble in H2O; ≥17.67 mg/mL
B6194 GSK481

Summary: RIP1(Receptor Interacting Protein Kinase 1) inhibitor

Soluble in DMSO
B6109 CPI-1189

Summary: necrosis factor (TNF) alpha inhibitor

≥23.4 mg/mL
B1188 Lenalidomide hemihydrate

Summary: TNF-α secretion inhibitor

insoluble in H2O; insoluble in EtOH; ≥30.1 mg/mL
A4216 Thalidomide

Target: Ubiquitin E3 Ligases

Summary: Immunomodulatory agent,sedative drug,angiogenesis inhibitor

insoluble in H2O; insoluble in EtOH; ≥11.8 mg/mL
A4213 Necrostatin-1
32 Citation

Target: RIP kinases

Summary: RIP1 inhibitor

insoluble in H2O; ≥12.97 mg/mL
A4212 Pomalidomide (CC-4047)

Summary: Immunomodulator,antumor/anti-angiogenic

insoluble in EtOH; insoluble in H2O; ≥7.5 mg/mL
A4211 Lenalidomide (CC-5013)

Target: angiogenesis

Summary: Antineoplastic agent,inhibits angiogenesis

insoluble in EtOH; insoluble in H2O; ≥100.8 mg/mL
A3652 Necrostatin 2
3 Citation

Summary: In vitro necroptosis inhibitor

Soluble in DMSO